Learn how Prospection analysed real-world data and identified a shift towards newer novel agents for chronic lymphocytic leukemia (CLL) treatment, providing insights to support their client's launch planning, submission modelling and market preparations for their new treatment. Prospection analysed treatment...

Learn how Prospection helped a pharma client understand the real-world utilization of medicines for mantle cell lymphoma (MCL). With depth of experience and analytics expertise, Prospection was able to identify patient treatment profiles using Australian Pharmaceutical Benefits Scheme (PBS) data....

The Prospection Platform helped a top pharmaceutical company simplify complex brand decision making surrounding Pulmonary Arterial Hypertension (PAH) to support patient programs with the aim to deliver earlier diagnoses and better referral programs. Our analysis identified anomalies across geographies for...

Multiple Myeloma (MM) Awareness Month takes place every March to raise awareness about this uncommon and complex blood cancer that can often be difficult to diagnose in its early stages and challenging to manage, despite advances in treatment.  MM affects...

Patient-centric intelligence (PCI) is becoming increasingly important for improving outcomes for rare diseases, with over 300 million people living with them around the world. Treatment for these diseases can be expensive, time consuming and complex. From diagnosis to treatment, people...